Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$554M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$435M |
| 3 |
CERN
Cerner Corp
CERN
|
+$282M |
| 4 |
Norfolk Southern
NSC
|
+$238M |
| 5 |
ExxonMobil
XOM
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.35B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$966M |
| 4 |
NVIDIA
NVDA
|
+$768M |
| 5 |
AT&T
T
|
+$594M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.17% |
| 2 | Financials | 6.59% |
| 3 | Healthcare | 6.12% |
| 4 | Industrials | 4.26% |
| 5 | Consumer Discretionary | 3.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4101
Enviri
NVRI
$630M
| $1.45M | ﹤0.01% |
+118,708
| New | +$1.74M |
|
|
APN
4102
DELISTED
Apeiron Capital Investment Corp
APN
| $1.45M | ﹤0.01% |
+145,000
| New | +$1.44M |
|
4103
Patria Investments
PAX
$1.81B
| $1.45M | ﹤0.01% |
+81,194
| New | +$1.35M |
|
4104
Carlyle Secured Lending
CGBD
$741M
| $1.45M | ﹤0.01% |
100,433
-3,932
| -4% | -$55.7K |
|
4105
Modine Manufacturing
MOD
$10.2B
| $1.44M | ﹤0.01% |
159,737
-172,156
| -52% | -$1.69M |
|
|
IMAQ
4106
DELISTED
International Media Acquisition Corp. Class A Common Stock
IMAQ
| $1.44M | ﹤0.01% |
145,194
+101,810
| +235% | +$1M |
|
|
LYLT
4107
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
| $1.44M | ﹤0.01% |
+86,968
| New | +$2.16M |
|
|
TIGR
4108
UP Fintech Holding
TIGR
$847M
| $1.44M | ﹤0.01% |
292,778
-367,394
| -56% | -$1.65M |
|
4109
Liberty Media Series A
FWONA
$22.9B
| $1.43M | ﹤0.01% |
23,729
+18,703
| +372% | +$1.01M |
|
4110
Transportadora de Gas del Sur
TGS
$4.38B
| $1.43M | ﹤0.01% |
204,496
+39,064
| +24% | +$208K |
|
4111
Nature's Sunshine
NATR
$358M
| $1.43M | ﹤0.01% |
85,151
+50,957
| +149% | +$901K |
|
4112
Aviat Networks
AVNW
$272M
| $1.43M | ﹤0.01% |
46,507
-149,819
| -76% | -$4.37M |
|
|
QUOT
4113
DELISTED
Quotient Technology Inc
QUOT
| $1.43M | ﹤0.01% |
+224,249
| New | +$1.5M |
|
|
CTV
4114
DELISTED
Innovid Corp.
CTV
| $1.43M | ﹤0.01% |
236,692
+98,762
| +72% | +$541K |
|
4115
Lyell Immunopharma
LYEL
$348M
| $1.42M | ﹤0.01% |
14,093
-5,326
| -27% | -$645K |
|
|
COUP
4116
CALL
DELISTED
Coupa Software Incorporated
COUP
| $1.42M | ﹤0.01% |
14,000
+500
| +4% | +$60.5K |
|
4117
iRadimed
IRMD
$1.17B
| $1.42M | ﹤0.01% |
+31,716
| New | +$1.47M |
|
|
VNET
4118
VNET Group
VNET
$2B
| $1.42M | ﹤0.01% |
243,917
+214,518
| +730% | +$1.65M |
|
4119
Banzai International
BNZI
$6.33M
| $1.42M | ﹤0.01% |
15
+1
| +7% | +$97.7K |
|
4120
PUT
Charles River Laboratories
CRL
$12.8B
| $1.42M | ﹤0.01% |
+5,000
| New | +$1.54M |
|
4121
Ovid Therapeutics
OVID
$495M
| $1.42M | ﹤0.01% |
452,066
+66,299
| +17% | +$209K |
|
4122
PennantPark Floating Rate Capital
PFLT
$724M
| $1.42M | ﹤0.01% |
+105,032
| New | +$1.37M |
|
4123
Richmond Mutual Bancorp
RMBI
$255M
| $1.42M | ﹤0.01% |
83,096
+16,545
| +25% | +$277K |
|
4124
Fennec Pharmaceuticals
FENC
$377M
| $1.42M | ﹤0.01% |
252,679
-4,938
| -2% | -$24.9K |
|
|
BLSA
4125
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $1.42M | ﹤0.01% |
143,330
-10,613
| -7% | -$104K |
|
Similar funds
Millennium Management's Q1 2022 Portfolio in Review
As of Q1 2022, Millennium Management held 8,193 positions worth $189B, down 4.1% from $197B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Millennium Management's Q1 2022 filing shows 1,492 new, 2,450 increased, 2,453 reduced and 1,365 closed positions. Its largest new stake was Mondelez International: 1,780,636 shares worth $112M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.35B.
By sector, the portfolio is most concentrated in Technology at 7.2% of assets, down from 7.9% a quarter earlier, followed by Financials and Healthcare.
- Millennium Management's largest Q1 2022 buy was Mondelez International: 1,780,636 shares worth $112M.
- Millennium Management added most to iShares MSCI Emerging Markets ETF in Q1 2022, an estimated $554M increase.
- Millennium Management's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.35B.
- Millennium Management fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $532M.
- Millennium Management's ten largest holdings make up 24% of its $189B portfolio in Q1 2022.
- Millennium Management opened 1,492 new positions and closed 1,365 in Q1 2022.
- Millennium Management's portfolio value fell 4.1% quarter-over-quarter to $189B.
Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.